Sort
261,768 grants matching “gene therapy”
Coenzyme Q10 in Huntingtons Disease
$1,350,086Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2012 · NS
Clinical evaluation of mTORC1 inhibition for geroprotection.
$1,350,005Adam R Konopka · University Of Wisconsin-Madison · U01 · FY2023 · AG
New classes of optogenetic and chemogenetic tools with a feedback control
$1,350,000Wenjing Wang · University Of Michigan At Ann Arbor · DP2 · FY2022 · MH
Oxidative Stress, AMPK & Diabetic Cardiovascular Disease
$1,349,983Neil B Ruderman · Boston Medical Center · P01 · FY2006 · HL
Decrypting Variants of Uncertain Significance in Long-QT Syndrome
$1,349,864Alfred L George · Northwestern University At Chicago · R01 · FY2020 · HL
Biological functions and post-transcriptional regulation of microRNAs
$1,349,789Katherine McJunkin · National Institute Of Diabetes And Digestive And Kidney Diseases · ZII · FY2017 · DK
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
$1,349,670Linda C Giudice · University Of California, San Francisco · P01 · FY2023 · HD
Porphyrias Consortium
$1,349,667Robert J Desnick · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · DK
Novel Strategies for Brain Tumor Therapy
$1,349,527University Of Pittsburgh At Pittsburgh · P01 · FY2003 · NS
Characterization of and Treatment for Chemotherapy Neuropathy
$1,349,495Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2012 · CA
Clonal Hematopoiesis Aging Resiliency Mechanisms
$1,349,483Alexander Bick · Vanderbilt University Medical Center · R01 · FY2024 · AG
Identifying novel modes of oncogenic signaling in multiple myeloma
$1,349,480Ryan Young · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Coenzyme Q10 in Huntingtons Disease
$1,349,440Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2013 · NS
UCLA SPOTRIAS Center Application
$1,349,373University Of California Los Angeles · P50 · FY2004 · NS
Molecular Mechanisms Of Growth Control And Carcinogenesis
$1,349,334J. Silvio Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Oral Carcinogenesis
$1,349,334J. Silvio Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia
$1,349,116Roy H Hamilton · University Of Pennsylvania · R01 · FY2024 · AG
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia
$1,349,116Roy H Hamilton · University Of Pennsylvania · R01 · FY2023 · AG
programmed cell death in regulation of autoimmunity
$1,349,074Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR
Psychobiology and Treatment of Perimenopausal Mood Disorders
$1,349,041Peter Schmidt · National Institute Of Mental Health · ZIA · FY2023 · MH
Mechanistic basis of bacteriophages for the decolonization of vancomycin resistant enterococci in the intestine
$1,349,029Breck A Duerkop · University Of Colorado Denver · R01 · FY2025 · AI
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,348,882David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2016 · AI
Oxidative Stress, AMPK &Diabetic Cardiovascular Disease
$1,348,842Boston Medical Center · P01 · FY2005 · HL
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
$1,348,805Gregory B Melikian · Emory University · R01 · FY2022 · AI
MT-125 for the Therapeutic Treatment of Glioblastoma
$1,348,593Steven S Rosenfeld · Myosin Therapeutics Inc. · R42 · FY2024 · CA